Focus: Labcorp is a large-scale contract research organization (CRO) with 70,000 employees generating $12.2B in revenue, providing clinical trial services, laboratory testing, and drug development support to the pharmaceutical industry.
Profile data last refreshed 4h ago · AI intelligence enriched 2mo ago
Hot — 4552 jobs added in 30d
Net +2339 (4552 new, 2213 removed). Aggressive expansion phase.
4 recent layoff filings (12 mo) — 354 affected
Source: state DOL filings via Big Local News
Labcorp offers stable CRO employment with strong hiring momentum, but recent profitability decline warrants scrutiny into business fundamentals before committing.
Help build intelligence for Labcorp
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Labcorp's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
8-K Filing: GeneDx Holdings Corp. (WGS, WGSWW) (CIK 0001818331) — EX-99.1
EX-99.1
Labcorp stock (US50540R4092): investors weigh latest earnings and strategic moves - AD HOC NEWS
Labcorp stock (US50540R4092): investors weigh latest earnings and strategic moves AD HOC NEWS
Labcorp stock (US50540R4092): Q1 earnings beat with $4.25 EPS - AD HOC NEWS
Labcorp stock (US50540R4092): Q1 earnings beat with $4.25 EPS AD HOC NEWS
8-K Filing: FedEx Freight Holding Company, Inc. (FDXF) (CIK 0002082247) — EXHIBIT 99.1
EXHIBIT 99.1
8-K Filing: FEDEX CORP (FDX) (CIK 0001048911) — EXHIBIT 99.1
EXHIBIT 99.1
Labcorp stock (US50540R4092): Expands Epic Integration for Diagnostic Testing - AD HOC NEWS
Labcorp stock (US50540R4092): Expands Epic Integration for Diagnostic Testing AD HOC NEWS
Showing 6 of 10 news items
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Source: state DOL filings, aggregated via Big Local News
No visible compliance red flags or recent layoff announcements, but the 68% net income collapse warrants monitoring for potential restructuring announcements in upcoming quarters.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo